D.A. Davidson & CO. lessened its stake in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 9.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 120,593 shares of the company’s stock after selling 13,037 shares during the period. D.A. Davidson & CO.’s holdings in Nutrien were worth $5,397,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also modified their holdings of the company. Silchester International Investors LLP raised its holdings in Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock valued at $513,437,000 after buying an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Nutrien in the 3rd quarter valued at about $150,181,000. ARGA Investment Management LP raised its holdings in Nutrien by 25.7% in the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock valued at $270,396,000 after buying an additional 1,236,671 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in Nutrien by 78.8% in the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock valued at $121,271,000 after buying an additional 1,100,000 shares during the period. Finally, Toronto Dominion Bank raised its holdings in Nutrien by 11.9% in the 3rd quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after buying an additional 447,413 shares during the period. Hedge funds and other institutional investors own 63.10% of the company’s stock.
Nutrien Stock Performance
Shares of Nutrien stock opened at $52.35 on Thursday. The business has a 50-day simple moving average of $49.22 and a 200-day simple moving average of $48.16. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The company has a market cap of $25.71 billion, a PE ratio of 35.13, a P/E/G ratio of 1.14 and a beta of 0.81. Nutrien Ltd. has a one year low of $43.69 and a one year high of $60.87.
Wall Street Analysts Forecast Growth
NTR has been the topic of several research analyst reports. CIBC restated an “outperformer” rating and issued a $55.00 price objective (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Wells Fargo & Company boosted their price objective on shares of Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a report on Tuesday, January 28th. TD Securities dropped their target price on Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research report on Tuesday, November 12th. UBS Group lifted their target price on Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. Finally, Oppenheimer assumed coverage on Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $59.00.
Check Out Our Latest Report on NTR
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading
- Five stocks we like better than Nutrien
- How to Calculate Options Profits
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Dividend Capture Strategy: What You Need to Know
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.